Finance

Lists
3378:HKG
Hanx Biopharmaceuticals (Wuhan) Co Ltd
HK$29.08
-1.42%
(-0.42) 1D
Sep 8, 4:00:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3378...
Open
HK$28.04
High
HK$29.50
Low
HK$28.04
Mkt. cap
3.90B
Avg. vol.
0.00
Volume
1.60K
52-wk high
HK$33.80
52-wk low
HK$13.48
Shares outstanding
136.22M
No. of employees
60
Open
HK$28.04
High
HK$29.50
Low
HK$28.04
Mkt. cap
3.90B
Avg. vol.
0.00
Volume
1.60K
52-wk high
HK$33.80
52-wk low
HK$13.48
Shares outstanding
136.22M
No. of employees
60
About Hanx Biopharmaceuticals (Wuhan) Co Ltd
CEO-
Employees60
Founded2014
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
12.50K
12.50K
3.00K
3.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15.66M
15.66M
13.05M
13.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.03M
13.03M
13.96M
13.96M
Operating expense
28.66M
28.66M
26.82M
26.82M
Total operating expenses
28.66M
28.66M
26.82M
26.82M
Operating income
-28.65M
-28.65M
-26.81M
-26.81M
Other non operating income
-190.50K
-190.50K
-8.75M
-8.75M
EBT including unusual items
-29.00M
-29.00M
-22.47M
-22.47M
EBT excluding unusual items
-31.44M
-31.44M
-33.05M
-33.05M
Income tax expense
-12.17M
-12.17M
-5.85M
-5.85M
Effective tax rate
41.97%
41.97%
26.02%
26.02%
Other operating expenses
-24.50K
-24.50K
-191.00K
-191.00K
Net income
-18.22M
-18.22M
-18.44M
-18.44M
Net profit margin
-145,760.00%
-145,760.00%
-614,716.67%
-614,716.67%
Earnings per share
-
-
-
-
Interest and investment income
163.50K
163.50K
3.03M
3.03M
Interest expense
-2.77M
-2.77M
-519.50K
-519.50K
Net interest expenses
-2.60M
-2.60M
2.51M
2.51M
Depreciation and amortization charges
-
-
-
-
EBITDA
-28.15M
-28.15M
-26.09M
-26.09M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps